clopidogrel and Overweight

clopidogrel has been researched along with Overweight in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Friebel, J; Hassanein, A; Jakobs, K; Landmesser, U; Puccini, M; Rauch, C; Rauch, U1
Aradi, D; Gross, L; Hadamitzky, M; Hein-Rothweiler, R; Komócsi, A; Massberg, S; Merkely, B; Rizas, KD; Sibbing, D; Trenk, D1
Chen, Z; Mo, J; Wang, Y1
Schlemm, E; Schlemm, L1
Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T1

Trials

1 trial(s) available for clopidogrel and Overweight

ArticleYear
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial.
    European heart journal. Cardiovascular pharmacotherapy, 2023, 11-02, Volume: 9, Issue:7

    Topics: Acute Coronary Syndrome; Clopidogrel; Hemorrhage; Humans; Ischemia; Overweight; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride

2023

Other Studies

4 other study(ies) available for clopidogrel and Overweight

ArticleYear
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
    Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:4

    Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Clopidogrel; Humans; Obesity; Overweight; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Ticlopidine

2023
Response by Chen et al to Letter Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity".
    Stroke, 2020, Volume: 51, Issue:3

    Topics: Alleles; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Obesity; Overweight; Stroke

2020
Letter by L. Schlemm and E. Schlemm Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity".
    Stroke, 2020, Volume: 51, Issue:3

    Topics: Alleles; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Obesity; Overweight; Stroke

2020
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
    British journal of pharmacology, 2022, Volume: 179, Issue:1

    Topics: Animals; Blood Platelets; Clopidogrel; Humans; Mice; Obesity; Overweight; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2022